Index RUT
P/E -
EPS (ttm) -0.91
Insider Own 11.97%
Shs Outstand 41.79M
Perf Week -0.74%
Market Cap 554.95M
Forward P/E -
EPS next Y -0.63
Insider Trans -1.14%
Shs Float 36.92M
Perf Month 2.13%
Income -37.40M
PEG -
EPS next Q -0.15
Inst Own 89.87%
Short Float 3.01%
Perf Quarter -13.53%
Sales 157.03M
P/S 3.53
EPS this Y 30.26%
Inst Trans -1.31%
Short Ratio 2.97
Perf Half Y 6.00%
Book/sh 3.95
P/B 3.40
EPS next Y 20.47%
ROA -16.34%
Short Interest 1.11M
Perf Year -31.84%
Cash/sh 3.65
P/C 3.68
EPS next 5Y 8.90%
ROE -22.09%
52W Range 11.70 - 21.70
Perf YTD -36.06%
Dividend Est. -
P/FCF -
EPS past 5Y 12.47%
ROI -18.49%
52W High -38.16%
Beta 1.18
Dividend TTM -
Quick Ratio 7.22
Sales past 5Y 20.39%
Gross Margin 77.70%
52W Low 14.70%
ATR (14) 0.73
Dividend Ex-Date -
Current Ratio 8.25
EPS Y/Y TTM 23.22%
Oper. Margin -26.91%
RSI (14) 49.33
Volatility 5.15% 5.18%
Employees 344
Debt/Eq 0.24
Sales Y/Y TTM 18.98%
Profit Margin -23.82%
Recom 1.00
Target Price 22.78
Option/Short Yes / Yes
LT Debt/Eq 0.23
EPS Q/Q 36.68%
Payout -
Rel Volume 0.48
Prev Close 13.61
Sales Surprise -0.36%
EPS Surprise 33.03%
Sales Q/Q 18.60%
Earnings Nov 12 AMC
Avg Volume 374.33K
Price 13.42
SMA20 2.13%
SMA50 0.04%
SMA200 -7.60%
Trades
Volume 181,190
Change -1.40%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-06-24 Reiterated
Needham
Buy
$27 → $19
Mar-28-24 Initiated
Piper Sandler
Overweight
$25
Oct-12-22 Initiated
Jefferies
Buy
$20
Apr-07-22 Resumed
Cantor Fitzgerald
Overweight
$34
Jun-08-21 Initiated
Citigroup
Buy
$40
Mar-09-21 Reiterated
Needham
Buy
$35 → $34
Dec-16-20 Reiterated
Needham
Buy
$28 → $35
Aug-04-20 Reiterated
Needham
Buy
$22 → $24
Jun-16-20 Resumed
Cantor Fitzgerald
Overweight
$25
May-05-20 Reiterated
Needham
Buy
$27 → $22
Feb-19-20 Initiated
Needham
Buy
$27
Jan-08-20 Initiated
SunTrust
Buy
$27
Dec-18-19 Initiated
Cantor Fitzgerald
Overweight
$27
Nov-12-18 Initiated
Morgan Stanley
Overweight
$24
Nov-12-18 Initiated
JMP Securities
Mkt Outperform
$27
Nov-12-18 Initiated
Canaccord Genuity
Buy
$25
Nov-12-18 Initiated
BofA/Merrill
Buy
$23
Show Previous Ratings
Dec-12-24 09:55AM
Nov-26-24 09:55AM
Nov-20-24 04:09PM
Nov-13-24 10:54AM
(Thomson Reuters StreetEvents) -15.93%
02:18AM
05:25PM
Loading…
Nov-12-24 05:25PM
04:21PM
(Associated Press Finance)
04:09PM
Nov-11-24 07:13AM
Nov-05-24 08:30AM
Oct-30-24 03:35AM
Oct-22-24 04:09PM
Oct-14-24 07:28AM
Oct-10-24 08:30AM
Aug-26-24 09:55AM
08:19AM
Loading…
08:19AM
Aug-22-24 04:30PM
Aug-20-24 08:30AM
Aug-08-24 09:55AM
Aug-06-24 09:16AM
(Thomson Reuters StreetEvents)
08:30AM
Aug-05-24 05:55PM
04:55PM
(Associated Press Finance)
04:09PM
Jul-15-24 04:09PM
Jun-05-24 04:09PM
May-07-24 11:16AM
09:00AM
08:04AM
(Thomson Reuters StreetEvents)
03:08AM
05:25PM
Loading…
May-06-24 05:25PM
04:24PM
(Associated Press Finance)
04:09PM
Apr-29-24 10:00AM
09:00AM
Apr-15-24 04:09PM
Mar-04-24 04:09PM
Feb-27-24 06:49AM
(Thomson Reuters StreetEvents) -13.53%
Feb-26-24 05:38PM
(Associated Press Finance)
04:34PM
04:09PM
Feb-19-24 10:00AM
Feb-05-24 04:09PM
Jan-30-24 08:30AM
Jan-22-24 10:54AM
Jan-08-24 08:30AM
Jan-05-24 09:02AM
Nov-30-23 09:30AM
Nov-21-23 07:03AM
Nov-14-23 04:09PM
Nov-07-23 11:08AM
10:00AM
(Thomson Reuters StreetEvents)
Nov-06-23 05:38PM
(Associated Press Finance)
05:01PM
04:09PM
Nov-01-23 04:09PM
Oct-16-23 04:09PM
Oct-09-23 12:00PM
Sep-08-23 09:40AM
Sep-06-23 09:55AM
Sep-05-23 04:09PM
Aug-29-23 04:09PM
Aug-09-23 10:07AM
Aug-08-23 06:23AM
(Thomson Reuters StreetEvents) -11.17%
Aug-07-23 05:20PM
04:09PM
Jul-19-23 04:09PM
Jul-17-23 04:09PM
Jul-06-23 10:00AM
May-29-23 10:15AM
May-24-23 04:09PM
May-04-23 10:29PM
04:09PM
12:00PM
May-02-23 02:12PM
10:33AM
(Thomson Reuters StreetEvents)
May-01-23 06:05PM
04:09PM
Apr-24-23 04:09PM
04:50AM
Apr-18-23 07:10AM
Apr-10-23 04:09PM
Mar-10-23 06:56AM
Mar-01-23 05:26AM
Feb-28-23 04:13PM
09:52AM
(Thomson Reuters StreetEvents)
Feb-27-23 05:35PM
04:09PM
Feb-20-23 10:00AM
Feb-06-23 04:09PM
Jan-09-23 09:00AM
Jan-03-23 04:09PM
Dec-27-22 08:30AM
Dec-01-22 09:01AM
Nov-07-22 05:35PM
04:09PM
Oct-31-22 10:00AM
Oct-17-22 04:04PM
Sep-11-22 09:22AM
Aug-29-22 09:55AM
SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DUNN JEFFREY W Director Nov 18 '24 Sale 12.43 1,609 20,001 20,431 Nov 20 05:13 PM RECUPERO ANTHONY J President, Commercial Ops Nov 18 '24 Sale 12.60 3,937 49,609 228,554 Nov 20 05:12 PM RECUPERO ANTHONY J President, Commercial Ops Nov 19 '24 Sale 12.17 2,070 25,195 226,484 Nov 20 05:12 PM Maheshwari Anshul Chief Financial Officer Nov 18 '24 Sale 12.68 2,439 30,937 194,623 Nov 20 05:11 PM FRANCIS LAURA Chief Executive Officer Nov 18 '24 Sale 12.58 10,048 126,354 482,875 Nov 20 05:10 PM ANTHONY JOHN RECUPERO Officer Nov 19 '24 Proposed Sale 12.36 2,070 25,585 Nov 19 04:24 PM DUNN JEFFREY W Director Nov 04 '24 Sale 13.55 341 4,621 22,040 Nov 06 06:19 PM RECUPERO ANTHONY J President, Commercial Ops Oct 02 '24 Sale 13.58 3,305 44,877 233,412 Oct 04 06:55 PM RECUPERO ANTHONY J President, Commercial Ops Oct 03 '24 Sale 13.60 921 12,526 232,491 Oct 04 06:55 PM Maheshwari Anshul Chief Financial Officer Oct 02 '24 Sale 13.58 3,305 44,886 197,062 Oct 04 06:54 PM ANTHONY JOHN RECUPERO Officer Oct 03 '24 Proposed Sale 13.60 921 12,526 Oct 03 04:28 PM Maheshwari Anshul Chief Financial Officer Sep 03 '24 Sale 16.35 1,414 23,119 200,367 Sep 04 05:51 PM ANSHUL MAHESHWARI Officer Sep 03 '24 Proposed Sale 16.62 1,414 23,501 Sep 03 04:21 PM RECUPERO ANTHONY J President, Commercial Ops Aug 16 '24 Sale 13.84 3,905 54,037 238,804 Aug 20 07:54 PM RECUPERO ANTHONY J President, Commercial Ops Aug 19 '24 Sale 14.17 2,087 29,569 236,717 Aug 20 07:54 PM Maheshwari Anshul Chief Financial Officer Aug 16 '24 Sale 13.87 2,418 33,538 198,762 Aug 20 07:53 PM FRANCIS LAURA Chief Executive Officer Aug 16 '24 Sale 13.84 9,967 137,970 492,923 Aug 20 07:52 PM DUNN JEFFREY W Director Aug 16 '24 Sale 13.84 1,580 21,867 25,212 Aug 20 07:51 PM ANTHONY JOHN RECUPERO Officer Aug 19 '24 Proposed Sale 13.87 2,087 28,947 Aug 19 04:27 PM DUNN JEFFREY W Director Aug 02 '24 Sale 14.32 343 4,912 26,792 Aug 06 05:38 PM RECUPERO ANTHONY J President, Commercial Ops Jul 02 '24 Sale 12.92 3,309 42,755 243,629 Jul 05 05:48 PM RECUPERO ANTHONY J President, Commercial Ops Jul 03 '24 Sale 13.05 920 12,007 242,709 Jul 05 05:48 PM Maheshwari Anshul Chief Financial Officer Jul 02 '24 Sale 12.90 3,309 42,694 201,180 Jul 05 05:41 PM FRANCIS LAURA Chief Executive Officer Jun 14 '24 Option Exercise 4.38 68,669 300,710 512,753 Jun 17 08:20 PM DUNN JEFFREY W Director Jun 10 '24 Sale 12.99 341 4,430 18,814 Jun 12 08:36 PM RECUPERO ANTHONY J President, Commercial Ops May 16 '24 Sale 15.10 3,941 59,502 247,592 May 17 08:08 PM RECUPERO ANTHONY J President, Commercial Ops May 17 '24 Sale 14.84 2,068 30,692 246,938 May 17 08:08 PM Maheshwari Anshul Chief Financial Officer May 16 '24 Sale 15.14 2,441 36,954 204,241 May 17 08:06 PM DUNN JEFFREY W Director May 16 '24 Sale 15.13 1,581 23,922 21,512 May 17 08:05 PM DUNN JEFFREY W Director May 02 '24 Sale 14.54 343 4,986 23,566 May 02 04:32 PM RECUPERO ANTHONY J President, Commercial Ops Apr 02 '24 Sale 15.50 3,307 51,272 252,453 Apr 04 07:59 PM RECUPERO ANTHONY J President, Commercial Ops Apr 03 '24 Sale 15.63 920 14,379 251,533 Apr 04 07:59 PM Maheshwari Anshul Chief Financial Officer Apr 02 '24 Sale 15.45 2,425 37,474 205,516 Apr 04 07:59 PM RECUPERO ANTHONY J President, Commercial Ops Mar 13 '24 Sale 16.82 3,330 56,023 255,760 Mar 14 05:46 PM Nishimura Mika Director Mar 13 '24 Sale 16.22 2,500 40,550 19,350 Mar 14 05:45 PM FRANCIS LAURA Chief Executive Officer Feb 16 '24 Sale 20.95 38,587 808,591 501,476 Feb 21 04:22 PM DUNN JEFFREY W Director Feb 16 '24 Sale 20.95 4,160 87,173 40,223 Feb 21 04:21 PM RECUPERO ANTHONY J President, Commercial Ops Feb 16 '24 Sale 20.95 7,822 163,910 259,090 Feb 21 04:20 PM Maheshwari Anshul Chief Financial Officer Feb 16 '24 Sale 20.96 7,336 153,726 207,941 Feb 21 04:20 PM DUNN JEFFREY W Director Feb 02 '24 Sale 20.30 335 6,799 44,383 Feb 05 07:53 PM Davis Timothy E JR Director Jan 02 '24 Option Exercise 3.24 21,111 68,400 43,472 Jan 09 06:01 PM Davis Timothy E JR Director Jan 02 '24 Sale 20.93 9,900 207,221 22,361 Jan 04 06:08 PM RECUPERO ANTHONY J President, Commercial Ops Jan 02 '24 Sale 20.93 1,936 40,511 198,903 Jan 04 06:07 PM Maheshwari Anshul Chief Financial Officer Jan 02 '24 Sale 20.92 1,470 30,758 147,268 Jan 04 06:06 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite